• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

BD initiates first-in-human trial of sirolimus drug-coated balloon

August 18, 2022 By Danielle Kirsh

BD-logoBD today announced it started enrollment in the first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB).

The Prevision trial is a prospective, multi-center, single-arm, non-randomized study that will evaluate the safety of BD’s DCB in the treatment of peripheral arterial disease (PAD) in the femoropopliteal arteries. The company initiated the trial to determine the viability of sirolimus as a treatment option for people with PAD.

“PAD impacts more than 200 million people across the globe and is often associated with morbidity, functional declines and higher health care costs. BD is committed to delivering much-needed solutions to address these challenges,” said Paddy O’Brien, worldwide president of BD peripheral intervention. “The launch of our Prevision first-in-human study demonstrates our ongoing commitment to advancing the drug-coated balloon category. It marks an important milestone on the path towards bringing this technology to clinicians and patients around the globe.”

BD’s first patient in the study was successfully treated by Dr. Andrew Holden, principal investigator at Aukland City Hospital in New Zealand.

“It is an honor to enroll the first patient in the Prevision study,” said Dr. Holden. “The burden of PAD continues to impact patients and challenge physicians around the globe. A continued focus on developing next-generation technology is important for the patients suffering from PAD.”

The Prevision trial will be conducted across multiple sites in Australia, New Zealand and Singapore. The trial will enroll and follow up on approximately 50 patients.

BD was one of the first companies to receive FDA approval for a paclitaxel drug-coated balloon in 2014. It has continued to innovate the balloon technology with advances such as additional indications, lower sheath profile, longer treatment lengths and additional guidewire configurations. The technology is currently used as an endovascular interventional treatment option for patients with PAD in the femoropopliteal arteries.

Filed Under: Balloons, Catheters Tagged With: BD

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Tubing + Extrusion, Medical Design & Outsourcing and MassDevice. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS